143 related articles for article (PubMed ID: 26138539)
1. Editorial. In silico ADMET predictions in pharmaceutical research.
Hou T
Adv Drug Deliv Rev; 2015 Jun; 86():1. PubMed ID: 26138539
[No Abstract] [Full Text] [Related]
2. The application of in silico drug-likeness predictions in pharmaceutical research.
Tian S; Wang J; Li Y; Li D; Xu L; Hou T
Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
[TBL] [Abstract][Full Text] [Related]
3. In Silico Meets In
Kar S; Chatterjee S
Curr Drug Metab; 2021; 22(7):502. PubMed ID: 34525918
[No Abstract] [Full Text] [Related]
4. Editorial: Theoretical Studies of the Metabolism in Drug Discovery.
Scotti MT; Scotti L
Curr Drug Metab; 2017; 18(6):498-499. PubMed ID: 28877659
[No Abstract] [Full Text] [Related]
5. Modeling ADMET.
Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
[TBL] [Abstract][Full Text] [Related]
6. In silico prediction of ADMET properties: how far have we come?
Dearden JC
Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
[TBL] [Abstract][Full Text] [Related]
7. What happened to the modeling and simulation revolution?
Bonate PL
Clin Pharmacol Ther; 2014 Oct; 96(4):416-7. PubMed ID: 25236664
[No Abstract] [Full Text] [Related]
8. Prediction of ADMET Properties.
Norinder U; Bergström CA
ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
[TBL] [Abstract][Full Text] [Related]
9. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
Yu XQ; Wilson AG
Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
[No Abstract] [Full Text] [Related]
10. Predicting Human Pharmacokinetics: Physiologically Based Pharmacokinetic Modeling and In Silico ADME Prediction in Early Drug Discovery.
Shi J; Zha W
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):135-137. PubMed ID: 30136219
[No Abstract] [Full Text] [Related]
11. Impact of modeling and simulation: myth or fact?
Allerheiligen SR
Clin Pharmacol Ther; 2014 Oct; 96(4):413-5. PubMed ID: 25236663
[No Abstract] [Full Text] [Related]
12. Metabolites: structure determination and prediction.
Cruciani G
Drug Discov Today Technol; 2013; 10(1):e145-6. PubMed ID: 24050243
[No Abstract] [Full Text] [Related]
13. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
14. ADMET modeling approaches in drug discovery.
Ferreira LLG; Andricopulo AD
Drug Discov Today; 2019 May; 24(5):1157-1165. PubMed ID: 30890362
[TBL] [Abstract][Full Text] [Related]
15. Beyond profiling: using ADMET models to guide decisions.
Segall M; Champness E; Obrezanova O; Leeding C
Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
[TBL] [Abstract][Full Text] [Related]
16. A "White Knight" role for DMPK researchers in pharmaceutical discovery: maximization of biomarker and translational M&S activities.
Teramura T
Drug Metab Pharmacokinet; 2012; 27(4):365-7. PubMed ID: 23268314
[No Abstract] [Full Text] [Related]
17. Cellular models for ADMET predictions and evaluation of drug-drug interactions.
Riley RJ; Kenna JG
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):86-99. PubMed ID: 14982152
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
Peters SA; Ungell AL; Dolgos H
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
[TBL] [Abstract][Full Text] [Related]
19. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
[TBL] [Abstract][Full Text] [Related]
20. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
